LAMPIT

This brand name is authorized in United States.

Active ingredients

The drug LAMPIT contains one active pharmaceutical ingredient (API):

`1`	Nifurtimox UNII `M84I3K7C2O` - NIFURTIMOX
	Nifurtimox is an antiprotozoal drug. It is used in pediatric patients for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi. Nifurtimox exposure-response relationships and the time course of pharmacodynamics response are unknown.
	Read more about Nifurtimox

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LAMPIT Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	50419-750, 50419-751

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.